These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38902306)
41. Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5. Bormann M; Brochhagen L; Alt M; Otte M; Thümmler L; van de Sand L; Kraiselburd I; Thomas A; Gosch J; Braß P; Ciesek S; Widera M; Dolff S; Dittmer U; Witzke O; Meyer F; Lindemann M; Schönfeld A; Rohn H; Krawczyk A Front Immunol; 2023; 14():1150667. PubMed ID: 37520539 [TBL] [Abstract][Full Text] [Related]
42. One health genomic surveillance and response to a university-based outbreak of the SARS-CoV-2 Delta AY.25 lineage, Arizona, 2021. Yaglom HD; Maurer M; Collins B; Hojnacki J; Monroy-Nieto J; Bowers JR; Packard S; Erickson DE; Barrand ZA; Simmons KM; Brock BN; Lim ES; Smith S; Hepp CM; Engelthaler DM PLoS One; 2022; 17(10):e0272830. PubMed ID: 36315517 [TBL] [Abstract][Full Text] [Related]
43. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study. Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536 [TBL] [Abstract][Full Text] [Related]
44. Repurposing an integrated national influenza platform for genomic surveillance of SARS-CoV-2 in Ghana: a molecular epidemiological analysis. Asante IA; Hsu SN; Boatemaa L; Kwasah L; Adusei-Poku M; Odoom JK; Awuku-Larbi Y; Foulkes BH; Oliver-Commey J; Asiedu EK; Parker MD; Mitja O; Eggo RM; de Oliveira-Martins L; Asiedu-Bekoe F; Laryea DO; Kuma-Aboagye P; Marks M; de Silva TI; Ampofo WK Lancet Glob Health; 2023 Jul; 11(7):e1075-e1085. PubMed ID: 37349034 [TBL] [Abstract][Full Text] [Related]
45. Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex. Robles-Escajeda E; Mohl JE; Contreras L; Betancourt AP; Mancera BM; Kirken RA; Rodriguez G Viruses; 2023 Feb; 15(3):. PubMed ID: 36992367 [TBL] [Abstract][Full Text] [Related]
46. Genomic Surveillance of SARS-CoV-2 Variants in the Dominican Republic and Emergence of a Local Lineage. Paulino-Ramírez R; López P; Mueses S; Cuevas P; Jabier M; Rivera-Amill V Int J Environ Res Public Health; 2023 Apr; 20(8):. PubMed ID: 37107785 [TBL] [Abstract][Full Text] [Related]
47. Whole genome analysis reveals unique traits of SARS-CoV-2 in pediatric patients. Chandy S; Kumar H; Pearl S; Basu S; M G; Sankar J; Manoharan A; Ramaiah S; Anbarasu A Gene; 2024 Aug; 919():148508. PubMed ID: 38670399 [TBL] [Abstract][Full Text] [Related]
48. Tracking SARS-CoV-2 variants of concern in wastewater: an assessment of nine computational tools using simulated genomic data. Sutcliffe SG; Kraemer SA; Ellmen I; Knapp JJ; Overton AK; Nash D; Nissimov JI; Charles TC; Dreifuss D; Topolsky I; Baykal PI; Fuhrmann L; Jablonski KP; Beerenwinkel N; Levy JI; Olabode AS; Becker DG; Gugan G; Brintnell E; Poon AFY; Valieris R; Drummond RD; Defelicibus A; Dias-Neto E; Rosales RA; Tojal da Silva I; Orfanou A; Psomopoulos F; Pechlivanis N; Pipes L; Chen Z; Baaijens JA; Baym M; Shapiro BJ Microb Genom; 2024 May; 10(5):. PubMed ID: 38785221 [TBL] [Abstract][Full Text] [Related]
49. Multiplex RT Real-Time PCR Based on Target Failure to Detect and Identify Different Variants of SARS-CoV-2: A Feasible Method That Can Be Applied in Clinical Laboratories. Pham VH; Pham HT; Balzanelli MG; Distratis P; Lazzaro R; Nguyen QV; Tran VQ; Tran DK; Phan LD; Pham SM; Pham BT; Duc CV; Nguyen HM; Nguyen DNT; Tran NV; Pham ST; Queck C; Nguyen KDC; Inchingolo F; Del Prete R; Nguyen NHD; Santacroce L; Gargiulo Isacco C Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189465 [TBL] [Abstract][Full Text] [Related]
50. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022. Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830 [TBL] [Abstract][Full Text] [Related]
51. Genomic characterization of the dominating Beta, V2 variant carrying vaccinated (Oxford-AstraZeneca) and nonvaccinated COVID-19 patient samples in Bangladesh: A metagenomics and whole-genome approach. Rahaman MM; Sarkar MMH; Rahman MS; Islam MR; Islam I; Saha O; Akter S; Banu TA; Jahan I; Habib MA; Goswami B; Bari L; Malek MA; Khan MS J Med Virol; 2022 Apr; 94(4):1670-1688. PubMed ID: 34939673 [TBL] [Abstract][Full Text] [Related]
52. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants. Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906 [TBL] [Abstract][Full Text] [Related]
53. Omicron variant genome evolution and phylogenetics. Kandeel M; Mohamed MEM; Abd El-Lateef HM; Venugopala KN; El-Beltagi HS J Med Virol; 2022 Apr; 94(4):1627-1632. PubMed ID: 34888894 [TBL] [Abstract][Full Text] [Related]
55. Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital. Obeid D; Al-Qahtani A; Almaghrabi R; Alghamdi S; Alsanea M; Alahideb B; Almutairi S; Alsuwairi F; Al-Abdulkareem M; Asiri M; Alshukairi A; Alkahtany J; Altamimi S; Mutabagani M; Althawadi S; Alanzi F; Alhamlan F J Infect Public Health; 2023 Feb; 16(2):171-181. PubMed ID: 36543031 [TBL] [Abstract][Full Text] [Related]
56. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers. ; Thompson MG; Yoon SK; Naleway AL; Meece J; Fabrizio TP; Caban-Martinez AJ; Burgess JL; Gaglani M; Olsho LEW; Bateman A; Lundgren J; Grant L; Phillips AL; Groom HC; Stefanski E; Solle NS; Ellingson K; Lutrick K; Dunnigan K; Wesley MG; Guenther K; Hunt A; Mak J; Hegmann KT; Kuntz JL; Bissonnette A; Hollister J; Rose S; Morrill TC; Respet K; Fowlkes AL; Thiese MS; Rivers P; Herring MK; Odean MJ; Yoo YM; Brunner M; Bedrick EJ; Fleary DE; Jones JT; Praggastis J; Romine J; Dickerson M; Khan SM; Lamberte JM; Beitel S; Webby RJ; Tyner HL JAMA; 2022 Oct; 328(15):1523-1533. PubMed ID: 36255426 [TBL] [Abstract][Full Text] [Related]
57. Regional reemergence of a SARS-CoV-2 Delta lineage amid an Omicron wave detected by wastewater sequencing. Haver A; Theijn R; Grift ID; Raaijmakers G; Poorter E; Laros JFJ; van Dissel JT; Lodder WJ Sci Rep; 2023 Oct; 13(1):17870. PubMed ID: 37857658 [TBL] [Abstract][Full Text] [Related]
58. Application of whole-genome tiling array at Shanghai port, China: An alternative method for SARS-CoV-2 surveillance. Liu D; Wang Z; Mao M; Zhang Z; Ding X; Zheng H; Li S; Zhang Z; Tian Z J Med Virol; 2023 Nov; 95(11):e29222. PubMed ID: 37964661 [TBL] [Abstract][Full Text] [Related]
59. Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples. Pipek OA; Medgyes-Horváth A; Stéger J; Papp K; Visontai D; Koopmans M; Nieuwenhuijse D; Oude Munnink BB; ; Csabai I Nat Commun; 2024 Jan; 15(1):517. PubMed ID: 38225254 [TBL] [Abstract][Full Text] [Related]
60. Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant. Sharma R; Zang W; Tabartehfarahani A; Lam A; Huang X; Sivakumar AD; Thota C; Yang S; Dickson RP; Sjoding MW; Bisco E; Mahmood CC; Diaz KM; Sautter N; Ansari S; Ward KR; Fan X JAMA Netw Open; 2023 Feb; 6(2):e230982. PubMed ID: 36853606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]